Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (ADImmune)

四价流感病毒裂解疫苗（国光生物）

Report date: 2022/10/17 17:14:01

Base Information

Drug NameInfluenza Vaccine (Split Virion), Inactivated, Quadrivalent (ADImmune)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Application > Prophylactic vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2022/01/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAdimmune Corp
China Registration ClassN/A

Develop Information

Active CompaniesAdimmune Corp
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A